Yesterday, Strategy (MSTR.US) decided to purchase 13.6k BTC, lifting its bitcoin holdings to nearly 687k BTC; the stock rose by more than 3% during yesterday’s U.S. session and is up by over 1% today ahead of the market open. It was the company’s largest purchase since summer 2025. Strategy’s shares are currently trading broadly in line with the value of the bitcoin it holds, suggesting a gradual stabilization compared with previous weeks, when the stock traded slightly below the value of its BTC reserves.
Strategy’s average BTC acquisition price is now roughly USD 75,000, which gives the company a fairly “solid cushion” in a downside scenario and is almost 1:1 consistent with the April 2025 correction low (panic triggered by Trump’s tariffs). Despite a stronger U.S. dollar, Bitcoin has stabilized around USD 90,000 and, after the latest dip, managed to rebound relatively quickly back toward USD 92,000. So far in 2026, demand for “hard assets” (mainly precious metals) has persisted despite the stronger dollar, which could ultimately also benefit Bitcoin.

Source: xStation5
MSTR (D1 timeframe)
MSTR shares are down nearly 70% from their highs, something that in recent years has typically occurred only during deep Bitcoin bear markets. On the one hand, the stock faces “competition” from spot Bitcoin ETFs, which reduce traditional-market demand for the company’s shares as a kind of “proxy” for direct BTC exposure. On the other hand, any return of a BTC bull market should clearly revive the stock from deeply oversold levels. The RSI and MACD indicators are turning upward, and if Bitcoin manages to break above USD 95,000, the rally in the stock price could accelerate meaningfully.

Source: xStation5
DE40: European equities overboughtโAll eyes on US CPI๐ก
JP Morgan's Net Income Down 7% on Investment Banking Miss
MP Materials rebounds 40% amid geopolitcal tensions ๐Are earth metals coming back?
Daily Summary: Conflict with the Fed Does Not Stop Wall Street๐
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.